BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16110792)

  • 21. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
    Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
    Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Invasive mycoses during hematopoietic stem cell transplantation].
    Popova MO; Zubarovskaia LS; Klimko NN; Vavilov VN; Volkova AG; Ziuzgin IS; Ignat'eva GM; Alianskiĭ AL; Paina OV; Babenko EV; Blagodarova-Smirnova MS; Smirnov BI; Afanas'ev BV
    Ter Arkh; 2012; 84(7):50-7. PubMed ID: 23038972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
    Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
    Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N;
    Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
    Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
    Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants.
    Iwen PC; Reed EC; Armitage JO; Bierman PJ; Kessinger A; Vose JM; Arneson MA; Winfield BA; Woods GL
    Infect Control Hosp Epidemiol; 1993 Mar; 14(3):131-9. PubMed ID: 8478525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
    Robin C; Cordonnier C; Sitbon K; Raus N; Lortholary O; Maury S; Peffault de la Tour R; Bretagne S; Bastuji-Garin S;
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):354-361. PubMed ID: 30268782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.
    Koenecke C; Hertenstein B; Schetelig J; van Biezen A; Dammann E; Gratwohl A; Ganser A; Schleuning M; Bornhäuser M; Jacobsen N; Kröger N; Niederwieser D; de Witte T; Ruutu T
    Am J Transplant; 2010 Aug; 10(8):1897-906. PubMed ID: 20659095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
    Klingspor L; Saaedi B; Ljungman P; Szakos A
    Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
    Neofytos D; Chatzis O; Nasioudis D; Boely Janke E; Doco Lecompte T; Garzoni C; Berger C; Cussini A; Boggian K; Khanna N; Manuel O; Mueller NJ; van Delden C;
    Transpl Infect Dis; 2018 Aug; 20(4):e12898. PubMed ID: 29668068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary Nocardia and Aspergillus co-infection in a patient with chronic graft-versus-host disease.
    Hamadani M; Benson DM; Blum W; Garzon R; Devine SM
    Transpl Infect Dis; 2008 Feb; 10(1):24-6. PubMed ID: 17651365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients.
    Erdmann JH; Graf B; Blau IW; Fischer F; Timm G; Hemmati P; Arnold R; Penack O
    Transpl Infect Dis; 2016 Jun; 18(3):354-60. PubMed ID: 26998687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
    Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
    BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epidemiology of invasive pulmonary aspergillosis at a large teaching hospital.
    Pegues CF; Daar ES; Murthy AR
    Infect Control Hosp Epidemiol; 2001 Jun; 22(6):370-4. PubMed ID: 11519915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Invasive fungal infections after allogeneic hematopoietic stem cell transplantation and related risk factors].
    Wang ZY; Jiang EL; Zhang P; Wang H; Bao YS; Wang M; Feng SZ; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):618-22. PubMed ID: 18549641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.
    Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ
    Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.